EM0200
Osteo-Bed Bone Embedding Kit
Iniciar sesión para ver los precios por organización y contrato.
Acerca de este artículo
NACRES:
NA.47
UNSPSC Code:
12171500
Storage temp.:
room temp
application(s)
hematology
histology
storage temp.
room temp
Application
Suitable for use with large and small mineralized (undecalcified) bone sections. Yields clear, hard blocks for cutting sections. Not water-soluble.
Other Notes
Osteo-Bed Bone Embedding Solvent (O8639) is available to remove plastic from sections.
1 of 1
Este artículo | ||
|---|---|---|
| storage temp. room temp | storage temp. room temp | storage temp. room temp |
| application(s) hematology | application(s) hematology | application(s) hematology |
Solo componentes del kit
Referencia del producto
Descripción
- Osteo-Bed Bone Embedding Resin A (O8514) 900 mL
- Osteo-Bed Bone Embedding Catalyst (O8764) 2 x 12
signalword
Danger
target_organs
Respiratory system
Clase de almacenamiento
5.2 - Organic peroxides and self-reacting hazardous materials
flash_point_f
50.0 °F
flash_point_c
10 °C
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - ED ENV 1 - ED HH 1 - Eye Irrit. 2 - Flam. Liq. 2 - Org. Perox. D - Repr. 1B - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Contenido relacionado
Instructions
Lei Qin et al.
Journal of orthopaedic translation, 34, 60-72 (2022-05-27)
The key focal adhesion protein β1 integrin plays an essential role in early skeletal development. However, roles of β1 integrin expression in osteocytes during the regulation of bone homeostasis and mechanotransduction are incompletely understood. To study the in vivo function
Nur-Vaizura Mohamad et al.
International journal of medical sciences, 18(16), 3665-3673 (2021-11-19)
Menopause is the leading cause of osteoporosis for elderly women due to imbalanced bone remodelling in the absence of oestrogen. The ability of tocotrienol in reversing established bone loss due to oestrogen deficiency remains unclear despite the plenitude of evidence
Colin K Yee et al.
Clinical & experimental metastasis, 25(8), 903-911 (2008-09-25)
In the current study, we examine heparin's anti-metastatic properties by using a well-defined mouse model of osteolytic bone metastasis. C57BL/6 mice were treated with increasing doses of unfractionated heparin (15, 20, or 25 units/mouse) 30 min prior to the left
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| EM0200-1KT | 04061833609439 |